Data may be out of date. Our scheduled checks are behind: the last successful check of the sources finished 20 Oct 2026, 21:00 UTC (16 days ago), more than 36 hours ago. Checks normally run twice daily, so figures on this page may be out of date. See the service status.

Scotland · NHS Scotland MSAN

DDAVP® (Desmopressin) 0.01% w/v (100 micrograms/ml) intranasal solution

MSAN(2020)101 · Level 2 · issued 21 Oct 2020

Reference: MSAN(2020)101
Issued: 21 Oct 2020
Priority: Level 2
Valid until: mid-2021 as stated by the source
Source: Signed NHS Scotland notice (PDF) ↗

What the notice states

The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.

Product	Position	Resupply
remain available from Aspire Pharma Ltd and can fully support demand during this time	Available	—

Provenance

Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.

scot:msan:2020:101

Recorded: 13 Aug 2026 22:03 UTC
Capture route: Captured first-hand by ShortageSignal's scheduled check
Read from: NHS Scotland Medicine Supply Alert Notice (PDF)
Captured at: 13 Aug 2026 22:03 UTC
Content hash: d3a13a9fb00ca34c3bb18a9c415a3a5e20f0420544f889f01b5828cd6e8638b6
sha256 of the captured bytes — proves what was captured, not that the source was correct
Source document: https://www.publications.scot.nhs.uk/files/msan-2020-101.pdf ↗

From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.